Literature DB >> 20817203

Developmental changes in multivariate neuroanatomical patterns that predict risk for psychosis in 22q11.2 deletion syndrome.

Doron Gothelf1, Fumiko Hoeft, Takefumi Ueno, Lisa Sugiura, Agatha D Lee, Paul Thompson, Allan L Reiss.   

Abstract

The primary objective of the current prospective study was to examine developmental patterns of voxel-by-voxel gray and white matter volumes (GMV, WMV, respectively) that would predict psychosis in adolescents with 22q11.2 deletion syndrome (22q11.2DS), the most common known genetic risk factor for schizophrenia. We performed a longitudinal voxel-based morphometry analysis using structural T1 MRI scans from 19 individuals with 22q11.2DS and 18 typically developing individuals. In 22q11.2DS, univariate analysis showed that greater reduction in left dorsal prefrontal cortical (dPFC) GMV over time predicted greater psychotic symptoms at Time2. This dPFC region also showed significantly reduced volumes in 22q11.2DS compared to typically developing individuals at Time1 and 2, greater reduction over time in 22q11.2DS COMT(Met) compared to COMT(Val), and greater reduction in those with greater decline in verbal IQ over time. Leave-one-out Multivariate pattern analysis results (MVPA) on the other hand, showed that patterns of GM and WM morphometric changes over time in regions including but not limited to the dPFC predicted risk for psychotic symptoms (94.7-100% accuracy) significantly better than using univariate analysis (63.1%). Additional predictive brain regions included medial PFC and dorsal cingulum. This longitudinal prospective study shows novel evidence of morphometric spatial patterns predicting the development of psychotic symptoms in 22q11.2DS, and further elucidates the abnormal maturational processes in 22q11.2DS. The use of neuroimaging using MVPA may hold promise to predict outcome in a variety of neuropsychiatric disorders.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20817203      PMCID: PMC3000448          DOI: 10.1016/j.jpsychires.2010.07.008

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  26 in total

1.  Volumetric, connective, and morphologic changes in the brains of children with chromosome 22q11.2 deletion syndrome: an integrative study.

Authors:  Tony J Simon; Lijun Ding; Joel P Bish; Donna M McDonald-McGinn; Elaine H Zackai; James Gee
Journal:  Neuroimage       Date:  2005-01-08       Impact factor: 6.556

2.  High rates of schizophrenia in adults with velo-cardio-facial syndrome.

Authors:  K C Murphy; L A Jones; M J Owen
Journal:  Arch Gen Psychiatry       Date:  1999-10

3.  Regional cortical white matter reductions in velocardiofacial syndrome: a volumetric MRI analysis.

Authors:  W R Kates; C P Burnette; E W Jabs; J Rutberg; A M Murphy; M Grados; M Geraghty; W E Kaufmann; G D Pearlson
Journal:  Biol Psychiatry       Date:  2001-04-15       Impact factor: 13.382

4.  Brain anatomy in adults with velocardiofacial syndrome with and without schizophrenia: preliminary results of a structural magnetic resonance imaging study.

Authors:  Therese van Amelsvoort; Eileen Daly; Jayne Henry; Dene Robertson; Virginia Ng; Michael Owen; Kieran C Murphy; Declan G M Murphy
Journal:  Arch Gen Psychiatry       Date:  2004-11

5.  Children and adolescents with velocardiofacial syndrome: a volumetric MRI study.

Authors:  S Eliez; J E Schmitt; C D White; A L Reiss
Journal:  Am J Psychiatry       Date:  2000-03       Impact factor: 18.112

6.  Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.

Authors:  H M Lachman; D F Papolos; T Saito; Y M Yu; C L Szumlanski; R M Weinshilboum
Journal:  Pharmacogenetics       Date:  1996-06

7.  A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population.

Authors:  Lorenzo D Botto; Kristin May; Paul M Fernhoff; Adolfo Correa; Karlene Coleman; Sonja A Rasmussen; Robert K Merritt; Leslie A O'Leary; Lee-Yang Wong; E Marsha Elixson; William T Mahle; Robert M Campbell
Journal:  Pediatrics       Date:  2003-07       Impact factor: 7.124

8.  Deviant trajectories of cortical maturation in 22q11.2 deletion syndrome (22q11DS): a cross-sectional and longitudinal study.

Authors:  Marie Schaer; Martin Debbané; Meritxell Bach Cuadra; Marie-Christine Ottet; Bronwyn Glaser; Jean-Philippe Thiran; Stephan Eliez
Journal:  Schizophr Res       Date:  2009-12       Impact factor: 4.939

9.  A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome.

Authors:  R J Shprintzen; R B Goldberg; M L Lewin; E J Sidoti; M D Berkman; R V Argamaso; D Young
Journal:  Cleft Palate J       Date:  1978-01

10.  An experiment of nature: brain anatomy parallels cognition and behavior in Williams syndrome.

Authors:  Allan L Reiss; Mark A Eckert; Fredric E Rose; Asya Karchemskiy; Shelli Kesler; Melody Chang; Margaret F Reynolds; Hower Kwon; Al Galaburda
Journal:  J Neurosci       Date:  2004-05-26       Impact factor: 6.167

View more
  31 in total

Review 1.  Predicting the risk of psychosis onset: advances and prospects.

Authors:  Eric V Strobl; Shaun M Eack; Vaidy Swaminathan; Shyam Visweswaran
Journal:  Early Interv Psychiatry       Date:  2012-07-08       Impact factor: 2.732

2.  Working Memory Impairments in Chromosome 22q11.2 Deletion Syndrome: The Roles of Anxiety and Stress Physiology.

Authors:  Ashley F P Sanders; Diana A Hobbs; David D Stephenson; Robert D Laird; Elliott A Beaton
Journal:  J Autism Dev Disord       Date:  2017-04

3.  The brain basis of the phonological deficit in dyslexia is independent of IQ.

Authors:  Hiroko Tanaka; Jessica M Black; Charles Hulme; Leanne M Stanley; Shelli R Kesler; Susan Whitfield-Gabrieli; Allan L Reiss; John D E Gabrieli; Fumiko Hoeft
Journal:  Psychol Sci       Date:  2011-10-17

Review 4.  A review of feature reduction techniques in neuroimaging.

Authors:  Benson Mwangi; Tian Siva Tian; Jair C Soares
Journal:  Neuroinformatics       Date:  2014-04

Review 5.  Psychosis prediction and clinical utility in familial high-risk studies: selective review, synthesis, and implications for early detection and intervention.

Authors:  Jai L Shah; Neeraj Tandon; Matcheri S Keshavan
Journal:  Early Interv Psychiatry       Date:  2013-05-22       Impact factor: 2.732

6.  White matter microstructural abnormalities of the cingulum bundle in youths with 22q11.2 deletion syndrome: associations with medication, neuropsychological function, and prodromal symptoms of psychosis.

Authors:  Wendy R Kates; Amy K Olszewski; Matthew H Gnirke; Zora Kikinis; Joshua Nelson; Kevin M Antshel; Wanda Fremont; Petya D Radoeva; Frank A Middleton; Martha E Shenton; Ioana L Coman
Journal:  Schizophr Res       Date:  2014-07-25       Impact factor: 4.939

Review 7.  Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disorders.

Authors:  Michael R Hunsaker
Journal:  Prog Neurobiol       Date:  2012-01-13       Impact factor: 11.685

Review 8.  Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome.

Authors:  Matthew J Schreiner; Maria T Lazaro; Maria Jalbrzikowski; Carrie E Bearden
Journal:  Neuropharmacology       Date:  2012-10-23       Impact factor: 5.250

9.  The hippocampi of children with chromosome 22q11.2 deletion syndrome have localized anterior alterations that predict severity of anxiety.

Authors:  Julia A Scott; Naomi Goodrich-Hunsaker; Kristopher Kalish; Aaron Lee; Michael R Hunsaker; Cynthia M Schumann; Owen T Carmichael; Tony J Simon
Journal:  J Psychiatry Neurosci       Date:  2016-04       Impact factor: 6.186

Review 10.  Long-range dysconnectivity in frontal and midline structures is associated to psychosis in 22q11.2 deletion syndrome.

Authors:  E Scariati; M C Padula; M Schaer; S Eliez
Journal:  J Neural Transm (Vienna)       Date:  2016-04-19       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.